Alpha Teknova Inc. (TKNO) Business Metric Overview - Stocknear

Alpha Teknova Inc.

NASDAQ: TKNO · Real-Time Price · USD
4.36
0.12 (2.83%)
At close: Sep 05, 2025, 3:59 PM
4.37
0.23%
After-hours: Sep 05, 2025, 07:16 PM EDT

Alpha Teknova Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Clinical Solutions Revenue 2.06M 1.16M 1.85M 1.96M 1.56M 1.72M 879K 597K 3.65M 1.61M 772K 919K 2.94M 3.81M 2.44M 1.69M 1.59M
Clinical Solutions Revenue Growth +77.28% -37.19% -5.80% +25.50% -8.91% +95.45% +47.24% -83.66% +127.04% +108.42% -16.00% -68.77% -22.80% +56.29% +44.32% +6.09% n/a
Lab Essentials Revenue 7.79M 8.12M 6.82M 7.16M 7.64M 7.27M 6.69M 7.27M 7.58M 7.26M 6.93M 9.47M 8.39M 6.97M 6.74M 7.2M 6.46M
Lab Essentials Revenue Growth -4.00% +19.05% -4.79% -6.25% +5.12% +8.64% -8.06% -4.05% +4.46% +4.66% -26.78% +12.83% +20.33% +3.43% -6.27% +11.45% n/a
Other Product Revenue 435K 516K 597K 451K 411K 306K 300K 298K 293K 255K 185K 303K 354K 354K 432K 434K 227K
Other Product Revenue Growth -15.70% -13.57% +32.37% +9.73% +34.31% +2.00% +0.67% +1.71% +14.90% +37.84% -38.94% -14.41% 0.00% -18.06% -0.46% +91.19% n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Sep 30, 2021 Jun 30, 2021
Non-Us Revenue 510K 523K 501K 519K 386K 420K 495K 342K 452K 395K 277K 308K 405K 327K 278K 8.06M
Non-Us Revenue Growth -2.49% +4.39% -3.47% +34.46% -8.10% -15.15% +44.74% -24.34% +14.43% +42.60% -10.06% -23.95% +23.85% +17.63% -96.55% n/a
United States Revenue 9.78M 9.27M 8.76M 9.06M 9.23M 8.87M 7.37M 7.83M 11.07M 8.73M 7.61M 10.38M 11.29M 10.82M 9.11M n/a
United States Revenue Growth +5.45% +5.80% -3.24% -1.85% +4.04% +20.32% -5.81% -29.33% +26.92% +14.60% -26.68% -7.98% +4.30% +18.72% n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 6.5M 7.13M 6.88M 6.61M 6.94M 7.75M 8.43M 8.55M 8.12M 9.69M 10M 8.9M 9.66M 8.89M 8.07M 6.49M 4.74M 4.87M 4M 2.29M 2.14M 2M
Selling, General, and Administrative Revenue Growth -8.83% +3.74% +4.04% -4.77% -10.44% -8.04% -1.46% +5.33% -16.22% -3.13% +12.38% -7.85% +8.60% +10.20% +24.29% +36.90% -2.55% +21.50% +74.81% +7.21% +6.64% n/a
Research and Development Revenue 581K 552K 594K 627K 678K 860K 1.31M 1.4M 1.46M 1.4M 1.87M 1.93M 1.93M 2.01M 1.39M 1.37M 851K 700K 482K 358K 341K 326K
Research and Development Revenue Growth +5.25% -7.07% -5.26% -7.52% -21.16% -34.40% -6.16% -4.58% +4.95% -25.40% -2.86% -0.21% -4.17% +44.82% +1.31% +61.22% +21.57% +45.23% +34.64% +4.99% +4.60% n/a
Sales and Marketing Revenue 1.57M 1.64M 1.56M 1.64M 1.46M 1.67M 2.4M 2.41M 2.17M 2.34M 2.56M 2.4M 2.6M 1.6M 1.28M 885K 904K 705K 840K 558K 481K 349K
Sales and Marketing Revenue Growth -4.09% +5.33% -5.06% +12.64% -12.66% -30.57% -0.46% +10.95% -7.21% -8.44% +6.76% -7.74% +62.68% +24.47% +44.97% -2.10% +28.23% -16.07% +50.54% +16.01% +37.82% n/a